Skip to main content
ENLV
NASDAQ Life Sciences

Enlivex Amends Lind Note: Principal Jumps to $19.2M, Conversion Price Set at 80% of Market with $1.50 Floor Reserve

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$1.92
Mkt Cap
$32.317M
52W Low
$1.8
52W High
$31.5
52W Position info
6.7% above low
Off High info
94% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

ENLV is trading near its 52-week low of $1.8 (6.7% above the low).

Summary

Enlivex amended its $21M convertible note with Lind Global, increasing the principal to $19.2M, extending maturity, and setting a conversion price at 80% of market with a $1.50 reserve floor — implying massive potential dilution.


Key Events · Financing and Capital Events · ENLV

  • Principal Increased to $19.2M

    The outstanding principal was raised from ~$16.3M to $19.2M, a 17.5% increase, in consideration for the amendment terms.

  • Conversion Price Tied to 80% of Market

    The conversion price is now the lower of $40.37625 or 80% of the average of the three lowest daily VWAPs over the 20 trading days prior to conversion notice. At current prices, this implies a conversion price around $1.54, deeply dilutive.

  • 25M Share Reserve with $1.50 Floor

    The company must reserve 25M ordinary shares for conversion, assuming a $1.50 conversion price. This implies potential issuance of up to 12.8M shares, or ~76% of the current outstanding, if fully converted at that floor.

  • Maturity Extended Indefinitely

    Monthly payments reduced from $2.3M to $1.2M, with the holder able to waive payments and extend maturity month-by-month. The original March 2027 maturity is effectively replaced by a flexible schedule.


Analysis · ENLV · Life Sciences

Enlivex restructured its $21M convertible note with Lind Global, increasing the outstanding principal by 17.5% to $19.2M and extending the maturity indefinitely via reduced monthly payments. The conversion price is now the lower of $40.38 or 80% of the three lowest VWAPs over 20 days — a deeply dilutive formula at current prices. The company must reserve 25M shares for conversion, assuming a $1.50 floor, which implies potential issuance of up to 12.8M shares, or roughly 76% of the current outstanding. The market cap default was waived, but interest now accrues at 10% whenever the market cap is below $75M — a near certainty given the current ~$32M market cap. This amendment signals acute cash constraints and a willingness to accept highly dilutive terms to avoid default.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 48.2% of the 1980 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.20%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ENLV was trading at $1.92 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $32.3M. The 52-week trading range was $1.80 to $31.50. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ENLV - Latest Insights

ENLV
Nov 16, 2026, 8:42 AM EST
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $1.08
Real-time Price: $1.06 info
Change: -$0.020 (-2%) info
Market Cap: $1.716M info
ENLV
Nov 16, 2026, 8:00 AM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $1.06
Real-time Price: $1.06 info
Change: $0 (0%) info
Market Cap: $1.716M info
ENLV
Nov 02, 2026, 8:00 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.90
Real-time Price: $1.06 info
Change: -$0.840 (-44%) info
Market Cap: $1.716M info
ENLV
Oct 27, 2026, 8:59 AM EDT
Source: Seeking Alpha
Importance Score:
8
Price at Filing: $0.1722
Real-time Price: $1.06 info
Change: Reverse Stock Split info
Market Cap: $1.716M info
ENLV
Oct 27, 2026, 8:01 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.1722
Real-time Price: $1.06 info
Change: Reverse Stock Split info
Market Cap: $1.716M info